Showing results (191-200 of 340) with videos related to
Sort By:
Pageof 34
Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 2, 2005
Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosisWillemijn A K M Windt, Jai Prakash, Robbert Jan Kok, et al.Diabetes Care|July 28, 2004
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal diseaseAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.American Heart Journal|July 31, 2013
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trialBruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.Journal of the American Society of Nephrology : JASN|August 11, 2006
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screeningNynke Halbesma, Dirk-Sjoerd Kuiken, Auke H Brantsma, et al.Methods in Molecular Biology (Clifton, N.J.)|March 4, 2011
Omics-bioinformatics in the context of clinical dataGert Mayer, Georg Heinze, Harald Mischak, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 13, 2017
Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System InterventionSergei I Petrykiv, Gozewijn Dirk Laverman, Frederik Persson, et al.Annals of Internal Medicine|September 11, 2003
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysisTazeen H Jafar, Paul C Stark, Christopher H Schmid, et al.Kidney International. Supplement|October 16, 2004
Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLCJacoline W Brinkman, Stephan J L Bakker, Ron T Gansevoort, et al.Pageof 34